Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guizhou Medical Univ. PTP1B compound 5j: sourced facts only. name: "Among them, compound 5j exhibited dual inhibitory activity against α-glucosidase and PTP1B with IC₅₀ values of 30.57 ± 0.22 μM and 7.58 ± 1.96 μM, respectively." [PMID:40712233]; target: "Among them, compound 5j exhibited dual inhibitory activity against α-glucosidase and PTP1B with IC₅₀ values of 30.57 ± 0.22 μM and 7.58 ± 1.96 μM, respectively." [PMID:40712233]; developer: "State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Guizhou Medical University, Guian New Area, 561113, China; School of Pharmacy, Guizhou Medical University, Guian New Area, 561113, China." [PMID:40712233]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guizhou Medical Univ. PTP1B compound 5j.